Dr. Leticia Kawano-Dourado is a pulmonologist and clinical researcher at HCor Research Institute, and at the University of Sao Paulo, Sao Paulo, Brazil. Currently, she is on a sabbatical at the University of Paris, Paris, France. She does research in non-invasive support for acute respiratory failure as the PI of the RENOVATE trial, and in interstitial lung diseases. More recently, she shifted her research focus to COVID-19: 1. she is part of the Brazilian initiative Coalition Brazil COVID-19 that ran several RCT in drug repurposing in COVID in Brazil (published on the NEJM, JAMA, BMJ). 2. She is a member of the steering committee of the WHO O2CoV2 study, and 3. she is a panel member of the Guideline Development Group of the WHO Living Guidelines on Treatments for COVID-19. Dr. Kawano Dourado is also a gender equity advocate in Medicine.